Investors who acquired Babcock & Wilcox Enterprises, Inc. securities between November 5, 2025, and March 11, 2026, are being urged to contact legal counsel. Pomerantz LLP has filed a class action lawsuit alleging misconduct, targeting potential financial losses incurred by shareholders during this specific four-month window of market activity.
A 15% slide in Abeona Therapeutics stock has triggered a formal investigation by the New York-based Pomerantz LLP. The firm is currently probing whether the company or its leadership committed securities fraud following disclosures regarding revenue recognition issues related to its therapy, ZEVASKYN.
A 26.3% plunge in Bally’s Corporation stock following a liquidity warning has triggered a formal investigation by Pomerantz LLP. The legal firm is currently examining whether the company’s leadership and directors misled shareholders or engaged in unlawful business practices regarding the firm's financial stability and debt obligations.
Shares of EyePoint Pharmaceuticals plummeted 67% on August 17 after the company reported that its pivotal Phase 3 trial for the wet age-related macular degeneration treatment DURAVYU failed to meet key visual acuity benchmarks when measured against the industry-standard drug Eylea.
Pomerantz LLP has launched an investigation into LENZ Therapeutics following a sharp decline in the company’s stock price. The inquiry focuses on potential securities fraud or unlawful business practices, specifically examining whether leadership misled shareholders regarding the commercial performance of their flagship eye drop product, VIZZ.
The New York-based Pomerantz LLP is probing Hims & Hers Health, Inc. following a series of regulatory challenges and internal disputes that triggered significant stock volatility. The investigation focuses on potential securities fraud, centering on how the company handles sensitive patient data and manages its subscription billing operations.
The global in-building wireless market is poised for significant expansion, with forecasts indicating a climb from $25.37 billion in 2026 to $48.52 billion by 2032. Driven by the rapid rollout of 5G and rising demand for reliable indoor connectivity, the sector is expected to maintain a steady compound annual growth rate of 11.4%.
A 9.28% drop in share price following an earnings miss, compounded by the sudden departure of the Chief Financial Officer, has triggered a formal investigation into D-Wave Quantum Inc. New York-based Pomerantz LLP is now reviewing the company’s business practices for potential securities fraud and fiduciary misconduct.
A 45 percent single-day stock collapse following weak second-quarter earnings has triggered a formal investigation into AirSculpt Technologies. New York-based Pomerantz LLP is now scrutinizing the company’s leadership for potential securities fraud and unlawful business practices, inviting shareholders to participate in a prospective class-action lawsuit against the firm.
A 30 percent plunge in share price following an earnings miss has triggered a formal investigation into Dick’s Sporting Goods. New York-based Pomerantz LLP is now scrutinizing the retailer’s leadership to determine if the company misled shareholders regarding its financial health and the performance of its recent acquisitions.
A sharp decline in quarterly revenue and missed earnings targets have triggered a securities fraud investigation into EHang Holdings Limited. The Pomerantz Law Firm is now reviewing whether company leadership misled investors regarding the regulatory hurdles impacting the firm’s passenger flight operations in China following a recent aviation accident.
A 22.8% single-day share price collapse has triggered a formal investigation into Klarna Group plc. Investors are now questioning whether the fintech firm and its leadership engaged in securities fraud after the company slashed its annual revenue guidance and announced the imminent departure of two key executives.
A sharp drop in share prices following a series of disappointing financial disclosures has triggered a formal investigation by Pomerantz LLP into JinkoSolar Holding Co. The firm is examining whether the solar manufacturer and its leadership misled investors regarding the company’s financial health and operational stability throughout 2025 and 2026.
A 6.95% single-day stock drop following HCA Healthcare’s July 14, 2026, profit guidance cut has triggered a formal investigation by Pomerantz LLP. The firm is now examining whether the hospital operator and its leadership engaged in securities fraud or unlawful business practices that misled shareholders regarding recent financial performance.
Aramco and Quantinuum have signed a non-binding memorandum of understanding to investigate how quantum computing can solve complex challenges within the energy sector. The agreement focuses on preparing for fault-tolerant research by identifying specific industrial use cases and benchmarking various quantum modalities for future integration.
Investors who acquired York Space Systems shares following the company’s January IPO are facing mounting losses after allegations of contract deception surfaced. Pomerantz LLP has launched a class action suit, setting an October 30 deadline for shareholders to seek appointment as lead plaintiff in the ongoing securities fraud litigation.
As AI workloads force data center rack densities to unprecedented levels, Stäubli is moving to unify power distribution and thermal management. The company’s latest electrical connectors and universal quick disconnects, engineered for Open Compute Project v3 standards, aim to bridge the gap between high-current delivery and liquid cooling requirements.
As China and Egypt celebrate seven decades of diplomatic ties, PowerChina is scaling its footprint beyond generation into storage and local manufacturing. The firm currently manages 1.8 GW of wind capacity in the Gulf of Suez, signaling a strategic shift toward building a self-sustaining clean energy ecosystem in North Africa.
A 23.88% stock price collapse following Criteo S.A.’s second-quarter earnings report has triggered a formal investigation by Pomerantz LLP. The law firm is scrutinizing whether the company and its executives engaged in securities fraud or unlawful business practices, potentially impacting shareholders who saw shares plummet to $17.05 on August 5.
Scientists and R&D experts now have a dedicated pathway to master artificial intelligence in medicine through a new six-week executive program from the Nuffield Department of Medicine and 2U. The course bridges the gap between complex biomedical research and the practical, ethical, and regulatory realities of modern drug development.
Investors who suffered losses in Hertz Global Holdings are facing a September 22 deadline to seek lead plaintiff status in a newly filed securities class action. The litigation centers on allegations that company leadership misled shareholders regarding liquidity and financial health shortly before a massive capital raise triggered a market rout.
Investors who purchased UWM Holdings Corporation securities are joining a class action lawsuit following a dramatic 34.78% collapse in share price this August. The litigation centers on allegations of securities fraud, specifically concerning massive derivative losses incurred after a failed merger attempt with Two Harbors Investment Corp.
A 9.4% single-day stock drop following a disappointing fiscal report has triggered a formal investigation by Pomerantz LLP into Dr. Reddy's Laboratories. Attorneys are scrutinizing whether the pharmaceutical company and its leadership engaged in securities fraud or unlawful practices regarding recent production failures and financial disclosures.
US companies are bracing for a period of economic caution in 2027, projecting base-pay increase budgets of 3.5%. While this figure mirrors the 2026 data, the static nature of the numbers masks a growing internal struggle: how to reward specialized AI expertise without abandoning traditional, job-based compensation structures.
Bybit is removing the friction from digital asset spending by connecting its 80 million users to the Mesh payments network. The partnership allows customers to use their existing exchange balances directly for checkouts and account top-ups on Mesh-powered platforms, bypassing the need for manual withdrawals or asset transfers.
A sharp deviation from Wall Street expectations has triggered a formal investigation into Wolfspeed, Inc. New York-based Pomerantz LLP is probing potential securities fraud following the company's August 2026 earnings report, which revealed a massive revenue shortfall that sent shares tumbling by nearly 10 percent in a single session.
Automotive AI developer Spyne has officially joined the Fortellis Marketplace, bringing its Vini AI platform directly into the CDK ecosystem. The integration allows U.S. dealerships to plug automated customer engagement tools into their existing workflows, aiming to accelerate lead response times and streamline service communications.
A 25% single-day collapse in Lincoln Educational Services stock has triggered a formal investigation by Pomerantz LLP. The firm is probing whether the company’s leadership misled shareholders regarding systemic enrollment failures that emerged during the second quarter of 2026, potentially violating federal securities laws.
Hospital pharmacy teams currently forced to juggle manual compliance checks alongside medication intake now have an alternative. TraceLink and Omnicell have integrated their systems, embedding Drug Supply Chain Security Act verification directly into central pharmacy inventory management to remove the need for disconnected, time-consuming reporting processes.
A federal class action lawsuit has been initiated against Alibaba Group Holding Limited, targeting the company and its executives over alleged securities fraud. The litigation follows a volatile period for shareholders, triggered by the company's inclusion on a U.S. military blacklist and subsequent allegations of illicit AI technology access.
